Effects of high dose intravenous immunoglobulin in two severe corticosteroid insensitive asthmatic patients

Thorax

Volumn 52, Issue 7, 1997, Pages 662-664

  Vrugt, Bart ^a   Wilson, Susan ^b   Van Velzen, Edwin ^c   Bron, Aad ^c   Shute, Janis K ^b   Holgate, Stephen T ^b   Djukanovic, Ratko ^b   Aalbers, René ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c Dutch Asthma Centre   (Switzerland)

Author keywords

Asthma; Intravenous immunoglobulin

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FORMOTEROL; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 8; PREDNISOLONE; THEOPHYLLINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHUS BIOPSY; CASE REPORT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FIBEROPTIC BRONCHOSCOPY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOHISTOLOGY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030857827     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.7.662     Document Type: Article

References (6)

1. Mazer BD, Gelfand EW. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 1991;87:976-83.
2. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai J-J, Frew AJ, et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991;144:1016-25.
3. Hall PD. Immunomodulation with intravenous immunoglobulin. Pharmacotherapy 1993;13:564-73.
4. Blasczyk R, Westhoff U, Grosse-Wilde H. Soluble CD4, CDS, and HLA molecules in commercial immunoglobulin preparations, Lancet 1993;341:789-90.
5. Shute J. IL-8 is a potent eosinophil chemoattractant. Clin Exp Allergy 1994;24:203-6.
6. Sylvester I, Yoshimura T, Sticherling M, Schröder J-M, Ceska M, Peichl P, et al. Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest 1992;90: 471-81.